Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy

Table 2

The treatment and outcome of individual patients with recurrent membranous nephropathy.

Gender	Tx	RF-1	P-1	Status Tx1	Rx	RF-2	P-2	Status Tx2	RF-3	P-3	Status Tx3	RF-C	P-C
M	1	96	8	Functioning	Rituximab	—	—	—	—	—	—	104	4.8
M	1	198	9	Functioning	ACEi	—	—	—	—	—	—	120	2
M	2	135	2.4	Failed	ACEi	—	—	Failed*	—	—	—	HD	—
M	3	233	9.35	Failed	ACEi	237	3.75	Failed	200	8.02	Failed	HD	—
M	1	218	4.6	Failed	ACEi	—	—	—	—	—	—	HD	—
F	1	101	4	Functioning	ACEi	—	—	—	—	—	—	116	1.5
M	2	267	4	Failed	Sirolimus	—	—	Died	—	—	—	Died	—
M	1	179	4.5	Failed	ACEi	—	—	—	—	—	—	HD	—
M	1	106	1.5	Functioning	ACEi	—	—	—	—	—	—	120	1

Tx: total number of transplants; RF-1: renal function at time of biopsy of first transplant (umol/L); P-1: proteinuria at time of biopsy of first transplant (g/24 hr); Tx1: first transplant; Rx: treatment instituted for recurrent membranous nephropathy; RF-2: renal function at time of biopsy of second transplant (umol/L); P-2: proteinuria at time of biopsy of second transplant (g/24 hr); Tx2: second transplant; RF-3: renal function at time of biopsy of third transplant (umol/L); P-3: proteinuria at time of biopsy of third transplant (g/24 hr); Tx3: third transplant; RF-C: current renal function (umol/L); P-C: current proteinuria (g/24 hr); ACEi: angiotensin converting enzyme inhibitor; HD: hemodialysis.
*Transplant failed for unrelated reasons.